Results 181 to 190 of about 175,117 (320)
Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion. [PDF]
Sagar AS +5 more
europepmc +1 more source
Methimazole-Induced Pleural Effusion in the Setting of Graves’ Disease [PDF]
Le Yu Khine +5 more
openalex +1 more source
ABSTRACT This study investigated the impact of pretreatment nutritional status, psychological health, fatigue, and insomnia on outcomes of immune checkpoint inhibitors (ICIs) monotherapy in patients with advanced non‐small cell lung cancer (NSCLC). A total of 80 patients with stage IV NSCLC were enrolled.
Yu‐Xuan Zhu +2 more
wiley +1 more source
Diagnostic approach to pleural diseases: new tricks for an old trade. [PDF]
Maldonado F, Lentz RJ, Light RW.
europepmc +1 more source
ABSTRACT Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are indicated for advanced lung adenocarcinoma patients harboring susceptible EGFR mutations. The aim of this retrospective study was to compare the effectiveness of different generations of EGFR TKIs.
Chia‐Yu Kuo +9 more
wiley +1 more source
Asbestos and benign pleural diseases: a narrative review. [PDF]
Ferreiro L +3 more
europepmc +1 more source
Advances and controversies in pleural diseases. [PDF]
Porcel JM, Statophoulos G, Lee YC.
europepmc +1 more source
Protein glycosylation in lung cancer from a mass spectrometry perspective
Abstract Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi +2 more
wiley +1 more source
Thoracoscopy: medical versus surgical-in the management of pleural diseases. [PDF]
Shojaee S, Lee HJ.
europepmc +1 more source
CT-guided biopsy for diagnosis of malignant disease in pleural effusions [PDF]
Nick Maskell +2 more
openalex +1 more source

